@CNN: Panel members in a two-day public hearing held by the US Food and Drug Administration this week agreed that efforts should be made to better inform patients about the risks and benefits of breast implants https://t.co/sUUr7YgimO
Panel members in a two-day public hearing held by the US Food and Drug Administration this week agreed that efforts should be made to better inform patients about the risks and benefits of breast implants https://t.co/sUUr7YgimO
— CNN (@CNN) March 27, 2019